Who owns LIPOCINE INC NEW?
- Ticker: LPCN
- CUSIP Number: 53630x203
Tip: Access positions for across all investors
Analyze quarterly positions in Lipocine with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Lipocine stock
Who bought or sold LIPOCINE INC NEW this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Ikarian Capital | 509k | $4.1M | 155% | Mar 2026 |
|
| Squadron Capital Management | 450k | $3.6M | 100% | Mar 2026 |
|
| Diadema Partners | 261k | $2.1M | 100% | Dec 2025 |
|
| Vanguard Group | 222k | $1.8M | 0% | Dec 2025 |
|
| Vanguard Capital Management | 201k | $1.6M | 100% | Mar 2026 |
|
| AIGH Capital Management | 200k | $1.6M | 100% | Mar 2026 |
|
| Stempoint Capital | 160k | $1.3M | 100% | Mar 2026 |
|
| Boothbay Fund Management | 141k | $1.1M | 156% | Mar 2026 |
|
| Seven Fleet Capital Management | 125k | $998k | 100% | Mar 2026 |
|
| Birchview Capital | 112k | $893k | 100% | Mar 2026 |
|
| BlackRock | 89k | $713k | 0% | Mar 2026 |
|
| Mink Brook Asset Management | 67k | $534k | 100% | Mar 2026 |
|
| Geode Capital Management | 63k | $505k | 1% | Mar 2026 |
|
| Renaissance Technologies | 37k | $300k | 4% | Dec 2025 |
|
| Two Sigma Investments | 34k | $270k | 100% | Mar 2026 |
|
| Vanguard Fiduciary Trust | 32k | $259k | 100% | Mar 2026 |
|
| Citadel Advisors | 29k | $232k | 100% | Mar 2026 |
|
| Susquehanna International | 25k | $200k | -47% | Dec 2025 |
|
| ADAR1 Capital Management | 23k | $185k | 100% | Mar 2026 |
|
| Jane Street | 20k | $160k | 89% | Mar 2026 |
|
| Dimensional Fund Advisors | 19k | $153k | 58% | Mar 2026 |
|
| State Street Corporation | 19k | $150k | 0% | Dec 2025 |
|
| Persistent Asset Partners | 13k | $107k | -81% | Mar 2026 |
|
| Northern Trust | 13k | $106k | 0% | Dec 2025 |
|
| Ameriprise Financial | 11k | $92k | -29% | Mar 2026 |
|
| UBS Group | 3.5k | $28k | -38% | Mar 2026 |
|
| Wells Fargo & Company | 2.7k | $22k | 100% | Mar 2026 |
|
| Vanguard Global Advisers | 1.7k | $14k | 100% | Mar 2026 |
|
| Morgan Stanley | 574.00 | $4.6k | -24% | Mar 2026 |
|
| Caldwell Sutter Capital | 471.00 | $3.8k | 0% | Mar 2026 |
|
| Group One Trading | 132.00 | $1.1k | -19% | Mar 2026 |
|
| Advisor Group Holdings | 118.00 | $946.997200 | -95% | Dec 2025 |
|
| FMR | 77.00 | $618.002000 | 31% | Dec 2025 |
|
| SBI Securities | 67.00 | $535.001700 | 0% | Mar 2026 |
|
| Tidemark | 59.00 | $471.002900 | 0% | Mar 2026 |
|
| Royal Bank of Canada | 50.00 | $0 | 4900% | Mar 2026 |
|
| Bogart Wealth | 3.00 | $24.000000 | 100% | Mar 2026 |
|
| Farther Finance Advisors | 1.00 | $9.000000 | 100% | Mar 2026 |
|
Who sold out of Lipocine?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Barclays | Sep 2025 | 9.4k | $27k |
| Tower Research Capital | Sep 2025 | 1.2k | $3.3k |
| HighMark Wealth Management | Dec 2025 | 100.00 | $803.000000 |